{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-15",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Crumlin",
      "state": "N/A",
      "country": "United Kingdom",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "75263",
      "recalling_firm": "Randox Laboratories, Limited",
      "address_1": "Ardmore 55 The Diamond Road",
      "address_2": "N/A",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide Distribution The product was only distributed to US Consignees.",
      "recall_number": "Z-0725-2017",
      "product_description": "Magnesium on RX Imola analyser  IVD",
      "product_quantity": "15",
      "reason_for_recall": "According to the firm, Carry over was observed when the amylase or pancreatic amylase test is run directly before or after the Magnesium assay. An update is required to the RX Imola analyser running order and an acid wash recommended when setting up the magnesium assay. A correction was made to the IFU for the Magnesium assay and all RX Imola customers in the USA were contacted with the updated instruction.",
      "recall_initiation_date": "20160414",
      "center_classification_date": "20161208",
      "termination_date": "20170919",
      "report_date": "20161214",
      "code_info": "reagent: MG3880  analyser: RX4900"
    }
  ]
}